| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Huppert M et al. | Lung weight parallels disease severity in experimental coccidioidomycosis. | 1976 | Infect. Immun. | pmid:1002301 |
| Meyerhoff A | U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. | 1999 | Clin. Infect. Dis. | pmid:10028069 |
| Robinson PA et al. | Early mycological treatment failure in AIDS-associated cryptococcal meningitis. | 1999 | Clin. Infect. Dis. | pmid:10028076 |
| Streppel M et al. | Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal amphotericin B and itraconazole. | 1999 | Ann. Otol. Rhinol. Laryngol. | pmid:10030242 |
| Krcmery V et al. | Invasive infections due to Clavispora lusitaniae. | 1999 | FEMS Immunol. Med. Microbiol. | pmid:10030550 |
| Wise GJ et al. | Genitourinary candidiasis: diagnosis and treatment. | 1976 | J. Urol. | pmid:1003650 |
| Gregory RK et al. | Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia. | 1999 | Bone Marrow Transplant. | pmid:10037060 |
| Coccia L et al. | Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome. | 1999 | Arch. Ophthalmol. | pmid:10037581 |
| Jones J et al. | Scedosporium apiospermum of the orbit. | 1999 | Arch. Ophthalmol. | pmid:10037582 |
| Otsubo T et al. | In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus. | 1999 | Antimicrob. Agents Chemother. | pmid:10049253 |
| LeBrun M et al. | Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats. | 1999 | Antimicrob. Agents Chemother. | pmid:10049261 |
| Helmerhorst EJ et al. | Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. | 1999 | Antimicrob. Agents Chemother. | pmid:10049295 |
| Newland AC | The use of liposomal amphotericin B in the treatment of neutropenia-associated fungal infections: efficacy and cost-effectiveness. | 1999 | Br. J. Haematol. | pmid:10050732 |
| Gupte TE et al. | Experimental studies (in vitro) on polyene macrolide antibiotics with special reference to hamycin against Malassezia ovale. | 1999 | Comp. Immunol. Microbiol. Infect. Dis. | pmid:10051180 |
| Myoken Y et al. | Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies. | 1999 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:10052372 |
| Al Arishi H et al. | Liposomal amphotericin B in neonates with invasive candidiasis. | 1998 | Am J Perinatol | pmid:10064206 |
| Janes SM et al. | Invasive pulmonary aspergillosis in an insulin-dependent diabetic. | 1998 | Respir Med | pmid:10070575 |
| Walsh TJ et al. | Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. | 1999 | N. Engl. J. Med. | pmid:10072411 |
| Demaimay R et al. | Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons. | 1999 | J. Virol. | pmid:10074211 |
| Verweij PE et al. | Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. | 1999 | J. Clin. Microbiol. | pmid:10074549 |
| Calviño J et al. | Renal artery rupture secondary to pretransplantation Candida contamination of the graft in two different recipients. | 1999 | Am. J. Kidney Dis. | pmid:10074601 |
| Kordossis T et al. | First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. | 1998 | Med. Mycol. | pmid:10075504 |
| Ghannoum MA et al. | Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. | 1999 | J Chemother | pmid:10078778 |
| Bayer AS et al. | Candida peritonitis. Report of 22 cases and review of the English literature. | 1976 | Am. J. Med. | pmid:1008070 |
| Ringdén O et al. | Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation. | 1997 | Pediatr Transplant | pmid:10084772 |
| Mayhall CG et al. | Cutaneous protothecosis. Successful treatment with amphotericin B. | 1976 | Arch Dermatol | pmid:1008567 |
| Turner DL et al. | Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B. | 1999 | J. Infect. | pmid:10090510 |
| Schmid ML et al. | A perianal ulcer. | 1999 | Lancet | pmid:10093983 |
| Avet PP et al. | Endoscopic sinus surgery in the management of mucormycosis. | 1999 | J Neuroophthalmol | pmid:10098551 |
| Alva EM and Khayr W | Candida krusei sinusitis. | 1998 | Am J Ther | pmid:10099049 |
| Dupont B | [Exotic pulmonary mycoses]. | 1998 | Rev Pneumol Clin | pmid:10100342 |
| Guigay J et al. | [American pulmonary histoplasmosis caused by Histoplasma capsulatum]. | 1998 | Rev Pneumol Clin | pmid:10100343 |
| Ridente Y et al. | Absence in amphotericin B-spiked human plasma of the free monomeric drug, as detected by SERS. | 1999 | FEBS Lett. | pmid:10100859 |
| Lee W and Kwak Y | Antifungal susceptibility testing of Candida species by flow cytometry. | 1999 | J. Korean Med. Sci. | pmid:10102519 |
| Yoon SA et al. | High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. | 1999 | Antimicrob. Agents Chemother. | pmid:10103188 |
| Persson U et al. | Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses. | 1992 | Pharmacoeconomics | pmid:10147007 |
| Stewart A et al. | Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infections. | 1995 | Pharmacoeconomics | pmid:10155676 |
| Gilbert BE | Liposomal aerosols in the management of pulmonary infections. | 1996 | J Aerosol Med | pmid:10160201 |
| Dranitsaris G et al. | Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients. | 1998 | Pharmacoeconomics | pmid:10180750 |
| Park MK et al. | Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. | 1999 | Clin. Infect. Dis. | pmid:10194090 |
| Späth-Schwalbe E et al. | Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus. | 1999 | Clin. Infect. Dis. | pmid:10194097 |
| Santhi K et al. | Nonliposomal approach--a study of preparation of egg albumin nanospheres containing amphotericin-B. | 1999 | Drug Dev Ind Pharm | pmid:10194612 |
| Boyle JA and Swenson CE | ABELCET treatment. | 1999 | J Clin Pharmacol | pmid:10197303 |
| Kelsey SM et al. | Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study. | 1999 | Bone Marrow Transplant. | pmid:10197802 |
| Ellepola AN and Samaranayake LP | The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. | 1998 | Oral Dis | pmid:10200705 |
| Szekely A et al. | Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. | 1999 | J. Clin. Microbiol. | pmid:10203509 |
| Nicholson RA et al. | Inhibition of GABA-gated chloride channels by 12,14-dichlorodehydroabietic acid in mammalian brain. | 1999 | Br. J. Pharmacol. | pmid:10204999 |
| Shuster J | Amphotericin B lipid complex and respiratory distress. | 1999 | Nursing | pmid:10205512 |
| Marco F et al. | Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. | 1998 | Med. Mycol. | pmid:10206756 |
amphotericin b
amphotericin b is a lipid of Polyketides (PK) class. Amphotericin b often locates in Mitochondria.
Cross Reference
Introduction
To understand associated biological information of amphotericin b, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with amphotericin b?
There are no associated biomedical information in the current reference collection.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with amphotericin b
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with amphotericin b?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with amphotericin b?
There are no associated biomedical information in the current reference collection.
What lipids are associated with amphotericin b?
There are no associated biomedical information in the current reference collection.
What genes are associated with amphotericin b?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with amphotericin b?
There are no associated biomedical information in the current reference collection.